Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: Systematic review of observational studies

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Foroutan, Farid ^a,b   Guyatt, Gordon H ^a   O'Brien, Kathleen ^b   Bain, Eva ^b   Stein, Madeleine ^b   Bhagra, Sai ^b   Sit, Daegan ^a   Kamran, Rakhshan ^a   Chang, Yaping ^a   Devji, Tahira ^a   Mir, Hassan ^a   Manja, Veena ^a,c,d   Schofield, Toni ^b   Siemieniuk, Reed A ^a,e   Agoritsas, Thomas ^a,f   Bagur, Rodrigo ^g   Otto, Catherine M ^h   Vandvik, Per O ^i,j  

^a MCMASTER UNIVERSITY   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c UNIVERSITY AT BUFFALO   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ INNLANDET HOSPITAL TRUST   (Norway)

^j UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; HEART VALVE BIOPROSTHESIS; HUMAN; LENGTH OF STAY; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; VALVE DETERIORATION;

EID: 84990209727     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5065     Document Type: Article

References (112)

1. Nishimura RA, Otto CM, Bonow RO, et al. ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:2440-92. doi:10.1161/CIR. 0000000000000029 pmid:24589852.
2. Arsalan M, Walther T. Durability of prostheses for transcatheter aortic valve implantation. Nat Rev Cardiol 2016;13:360-7. doi:10.1038/nrcardio.2016.43 pmid:27053461.
3. Huygens SA, Mokhles MM, Hanif M, et al. Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2016;ezw101. doi:10.1093/ejcts/ezw101 pmid: 27026750.
4. Siemieniuk RA, Agoritsas T, Manja V, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis.BMJ ;2016:354:i5130.
5. Lytvyn L, Guyatt GH, Manja V, et al. Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review. BMJ Open 2016;6:e014327.
6. Vandvik PO, Otto CM, Siemieniuk RA, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ 2016:354:i5085.
7. Siemieniuk RA, Macdonald H, Agoritsas T, Guyatt GH, Brandt L, Vandvik PO. Introduction to BMJ Rapid Recommendations. BMJ 2016;354:i5191.
8. Cao C, Liou KP, Pathan FK, et al. Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Meta-Analysis of Clinical Outcomes and Cost-Effectiveness. Curr Pharm Des 2016;22:1965-77. doi:10.2174/1381612822666160219120713 pmid: 26891807.
9. Fabian J, Bass K, Fischer V, et al. [Dilated cardiomyopathy and heart transplantation]. Bratisl Lek Listy 1997;98:243-7.pmid:9296828.
10. Forli L, Bollerslev J, Simonsen S, et al. Disturbed energy metabolism after lung and heart transplantation. Clin Transplant 2011;25:E136-43. doi:10.1111/j.1399-0012.2010.01379. x pmid:21158927.
11. Actuarial Life Table, Social Security Administration, United States of America.www.ssa. gov/oact/STATS/table4c6.html.
12. Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013;158:280-6. doi:10.7326/0003-4819- 158-4-201302190-00009 pmid:23420236.
13. Iorio A, Spencer FA, Falavigna M, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ 2015;350:h870. doi:10.1136/bmj.h870 pmid:25775931.
14. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9. doi:10.1186/1471-2288-12-9 pmid:22297116.
15. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014;72:39. doi:10.1186/2049-3258-72-39 pmid: 25810908.
16. Review Manager (RevMan). (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
17. Habedank D, Hummel M, Hetzer R, Anker S. Reversibility of cardiac cachexia after heart transplantation. J Heart Lung Transplant 2005;24:1757-62. doi:10.1016/j.healun.2005. 02.003 pmid:16297777.
18. Accola KD, Scott ML, Palmer GJ, et al. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis. J Heart Valve Dis 2008;17:355-64, discussion 365.pmid:18751463.
19. Ali A, Patel A, Ali Z, et al. Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. J Thorac Cardiovasc Surg 2011;142:285-91. doi:10.1016/j.jtcvs.2010.08.084 pmid: 21272899.
20. Ashikhmina EA, Schaff HV, Dearani JA, et al. Aortic valve replacement in the elderly: determinants of late outcome. Circulation 2011;124:1070-8. doi:10.1161/ CIRCULATIONAHA.110.987560 pmid:21824918.
21. Aupart MR, Mirza A, Meurisse YA, Sirinelli AL, Neville PH, Marchand MA. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J Heart Valve Dis 2006;15:768-75, discussion 775-6.pmid:17152784.
22. Auriemma S, DOnofrio A, Brunelli M, et al. Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years follow up. J Heart Valve Dis 2006;15:691-5.pmid:17044376.
23. Aydin E, Yerlikhan OA, Tuzun B, Ozen Y, Sarikaya S, Kirali MK. How to approach aortic valve disease in the elderly: a 25-year retrospective study. Cardiovasc J Afr 2014;25:244-8. doi:10.5830/CVJA-2014-051 pmid:25629541.
24. Barone-Rochette G, Pierard S, De Meester de Ravenstein C, et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 2014;64:144-54. doi:10.1016/j.jacc.2014.02.612 pmid:25011718.
25. Benhameid O, Jamieson WR, Castella M, et al. CarboMedics Mitroflow pericardial aortic bioprosthesis - performance in patients aged 60 years and older after 15 years. Thorac Cardiovasc Surg 2008;56:195-9. doi:10.1055/s-2008-1038385 pmid:18481236.
26. Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg 2015;99:831-7. doi:10.1016/j.athoracsur.2014.09.030 pmid:25583467.
27. Bourguignon T, Lhommet P, El Khoury R, et al. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50-65 years. Eur J Cardiothorac Surg 2016;49:1462-8. doi:10.1093/ejcts/ezv384 pmid:26530269.
28. Rubio Alvarez J, Sierra Quiroga J, Vega Fernandez M, et al. Up to twenty-five-year survival after aortic valve replacement with size 19 mm valves. Interact Cardiovasc Thorac Surg 2010;10:32-5. doi:10.1510/icvts.2009.209197 pmid:19770137.
29. Christ T, Grubitzsch H, Claus B, Heinze G, Dushe S, Konertz W. Hemodynamic behavior of stentless aortic valves in long term follow-up. J Cardiothorac Surg 2014;9:197. doi:10. 1186/s13019-014-0197-2 pmid:25527116.
30. Concistre G, Dellaquila A, Pansini S, et al. Aortic valve replacement with smaller prostheses in elderly patients: does patient prosthetic mismatch affect outcomes? J Card Surg 2013;28:341-7. doi:10.1111/jocs.12136 pmid:23691967.
31. Dalen M, Biancari F, Rubino AS, et al. Ministernotomy versus full sternotomy aortic valve replacement with a sutureless bioprosthesis: a multicenter study. Ann Thorac Surg 2015;99:524-30. doi:10.1016/j.athoracsur.2014.08.028 pmid:25483001.
32. de Vincentiis C, Kunkl AB, Trimarchi S, et al. Aortic valve replacement in octogenarians: is biologic valve the unique solution? Ann Thorac Surg 2008;85:1296-301. doi:10.1016/j. athoracsur.2007.12.018 pmid:18355513.
33. Eichinger WB, Hettich IM, Ruzicka DJ, et al. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg 2008;86:1204-10. doi:10.1016/j.athoracsur.2008.05.058 pmid:18805161.
34. ElBardissi AW, Shekar P, Couper GS, Cohn LH. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg 2011;141:328-35. doi:10.1016/j.jtcvs.2010.08.056 pmid: 21047646.
35. Elhmidi Y, Piazza N, Mazzitelli D, Wottke M, Lange R, Bleiziffer S. Sex-related differences in 2197 patients undergoing isolated surgical aortic valve replacement. J Card Surg 2014;29:772-8. doi:10.1111/jocs.12442 pmid:25264220.
36. Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Silvay G, Adams DH. Excellent early and late outcomes of aortic valve replacement in people aged 80 and older. J Am Geriatr Soc 2008;56:255-61. doi:10.1111/j.1532-5415.2007.01535.x pmid:18047491.
37. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation 2010;121:2123-9. doi:10.1161/CIRCULATIONAHA.109.901272 pmid: 20439787.
38. Fuchs C, Mascherbauer J, Rosenhek R, et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart 2010;96:539-45. doi:10.1136/hrt.2009. 186650 pmid:20350991.
39. Gaudino M, Anselmi A, Glieca F, et al. Contemporary results for isolated aortic valve surgery. Thorac Cardiovasc Surg 2011;59:229-32. doi:10.1055/s-0030-1250640 pmid: 21409748.
40. Glauber M, Gilmanov D, Farneti PA, et al. Right anterior minithoracotomy for aortic valve replacement: 10-year experience of a single center. J Thorac Cardiovasc Surg 2015;150:548-56.e2. doi:10.1016/j.jtcvs.2015.06.045 pmid:26215359.
41. Grupper A, Beigel R, Maor E, et al. Survival after intervention in patients with low gradient severe aortic stenosis and preserved left ventricular function. J Thorac Cardiovasc Surg 2014;148:2823-7. doi:10.1016/j.jtcvs.2014.03.039 pmid:24787695.
42. Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122:1319-27. doi:10.1161/CIRCULATIONAHA.110.948877 pmid:20837893.
43. Gerckens U, et al. Four-year durability and patient survival with CoreValve transcatheter aortic valve. Eur Heart J 2011;32:169. doi:10.1093/eurheartj/ehr322. pmid:20978016.
44. Hong S, Yi G, Youn YN, Lee S, Yoo KJ, Chang BC. Effect of the prosthesis-patient mismatch on long-term clinical outcomes after isolated aortic valve replacement for aortic stenosis: a prospective observational study. J Thorac Cardiovasc Surg 2013;146:1098-104. doi:10.1016/j.jtcvs.2012.07.101 pmid:22959323.
45. Howell NJ, Keogh BE, Ray D, et al. Patient-prosthesis mismatch in patients with aortic stenosis undergoing isolated aortic valve replacement does not affect survival. Ann Thorac Surg 2010;89:60-4. doi:10.1016/j.athoracsur.2009.07.037 pmid:20103206.
46. Iturra SA, Suri RM, Greason KL, et al. Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era. J Thorac Cardiovasc Surg 2014;147:127-32. doi:10.1016/j.jtcvs.2013.08.036 pmid: 24094915.
47. Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation 2014;130:1483-92. doi:10.1161/CIRCULATIONAHA.114. 009834 pmid:25205802.
48. Kato Y, Tsutsumi Y, Kawai T, Goto T, Takahashi Y, Ohashi H. Aortic valve replacement for aortic stenosis in the elderly: influence of prosthesis-patient mismatch on late survival and left ventricular mass regression. Gen Thorac Cardiovasc Surg 2008;56:397-403. doi: 10.1007/s11748-008-0261-8 pmid:18696205.
49. Kobayashi KJ, Williams JA, Nwakanma L, Gott VL, Baumgartner WA, Conte JV. Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts. Ann Thorac Surg 2007;83:969-78. doi:10.1016/j.athoracsur.2006.10. pmid:17307443.
50. Kulik A, Burwash IG, Kapila V, Mesana TG, Ruel M. Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation 2006;114(Suppl):I553-8.pmid:16820636.
51. Levy F, Laurent M, Monin JL, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 2008;51:1466-72. doi:10.1016/j.jacc.2007.10.067 pmid:18402902.
52. Linneweber J, Heinbokel T, Christ T, Claus B, Kossagk C, Konertz W. Clinical experience with the ATS 3F stentless aortic bioprosthesis: five years follow up. J Heart Valve Dis 2010;19:772-7.pmid:21214103.
53. Matsumoto Y, Fujita T, Hata H, Shimahara Y, Sato S, Kobayashi J. Hemodynamic Performance and Durability of Mosaic Bioprostheses for Aortic Valve Replacement, up to 13 Years. Circ J 2015;79:1044-51. doi:10.1253/circj.CJ-14-0990 pmid:25740500.
54. McLean RC, Briggs AH, Slack R, et al. Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients. Eur J Cardiothorac Surg 2011;40:1508-14. doi:10.1016/j.ejcts.2011.01.088. pmid:21493086.
55. Muneretto C, Alfieri O, Cesana BM, et al. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in "real-world" patients with aortic stenosis and intermediate- to high-risk profile. J Thorac Cardiovasc Surg 2015;150:1570-7, discussion 1577-9. doi:10.1016/j.jtcvs.2015.08.052 pmid:26384753.
56. Muneretto C, Bisleri G, Moggi A, et al. Treating the patients in the grey-zone with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement. Interact Cardiovasc Thorac Surg 2015;20:90-5. doi:10.1093/icvts/ivu340 pmid:25320140.
57. Nyawo B, Graham R, Hunter S. Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up. J Heart Valve Dis 2007;16:42-8.pmid: 17315382.
58. Okamura H, Yamaguchi A, Nagano H, et al. Mid-term outcomes after aortic valve replacement with the 17-mm St. Jude Medical Regent valve. Circ J 2012;76:365-71. doi: 10.1253/circj.CJ-11-0733 pmid:22130314.
59. Oliveira SM, Correia AS, Paiva M, et al. Long-term survival, autonomy, and quality of life of elderly patients undergoing aortic valve replacement. J Card Surg 2012;27:20-3. doi: 10.1111/j.1540-8191.2011.01360.x pmid:22211277.
60. Papadopoulos N, Schiller N, Fichtlscherer S, et al. Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery. J Cardiothorac Surg 2014;9:99. doi:10.1186/1749-8090-9-99 pmid:24915763.
61. Petrov G, Dworatzek E, Schulze TM, et al. Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. JACC Cardiovasc Imaging 2014;7:1073-80. doi:10.1016/j.jcmg.2014.06.017 pmid:25306541.
62. Redlich K, Khaladj N, Peterss S, et al. Conventional aortic valve replacement in patients with concomitant coronary artery disease and previous coronary artery bypass grafting in the era of interventional approaches. Eur J Cardiothorac Surg 2011;40:455-62. doi:10. 1016/j.ejcts.2010.11.067. pmid:21256760.
63. Schymik G, Heimeshoff M, Bramlage P, et al. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk. Catheter Cardiovasc Interv 2015;86:738-44. doi:10.1002/ccd.25866 pmid:25641398.
64. Wenaweser P, Pilgrim T, Kadner A, et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol 2011;58:2151-62. doi:10.1016/j.jacc.2011.05.063 pmid:22078420.
65. Yamane K, Hirose H, Youdelman BA, Bogar LJ, Diehl JT. Conventional aortic valve replacement for elderly patients in the current era. Circ J 2011;75:2692-8. doi:10.1253/ circj.CJ-11-0541 pmid:21857141.
66. Christ T, Grubitzsch H, Claus B, Konertz W. Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age. J Thorac Cardiovasc Surg 2014;147:264-9. doi:10.1016/j.jtcvs.2012.10.032 pmid:23158257
67. Christ T, Grubitzsch H, Claus B, Konertz W. Stentless aortic valve replacement in the young patient: long-term results. J Cardiothorac Surg 2013;8:68. doi:10.1186/1749-8090- 8-68 pmid:23566631.
68. Joshi V, Prosser K, Richens D. Early prosthetic valve degeneration with Mitroflow aortic valves: determination of incidence and risk factors. Interact Cardiovasc Thorac Surg 2014;19:36-40. doi:10.1093/icvts/ivu033 pmid:24667584.
69. Anselmi A, Flecher E, Ruggieri VG, et al. Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position. J Thorac Cardiovasc Surg 2014;147:1884-91. doi:10.1016/j.jtcvs.2013.07.005 pmid:23988288.
70. Beholz S, Repossini A, Livi U, et al. The Freedom SOLO valve for aortic valve replacement: clinical and hemodynamic results from a prospective multicenter trial. J Heart Valve Dis 2010;19:115-23.pmid:20329497.
71. Dagenais F, Mathieu P, Doyle D, Dumont E, Voisine P. Moderate aortic stenosis in coronary artery bypass grafting patients more than 70 years of age: to replace or not to replace? Ann Thorac Surg 2010;90:1495-9, discussion 1499-500. doi:10.1016/j.athoracsur. 2010.06.036 pmid:20971247.
72. Ding WH, Lam YY, Pepper JR, et al. Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis. Int J Cardiol 2010;141:24-31. doi:10.1016/j.ijcard.2008.11.126 pmid:19138807.
73. Dubois C, Coosemans M, Rega F, et al. Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment. Interact Cardiovasc Thorac Surg 2013;17:492-500. doi:10.1093/icvts/ivt228 pmid: 23702465.
74. Ennker JA, Ennker IC, Albert AA, Rosendahl UP, Bauer S, Florath I. The Freestyle stentless bioprosthesis in more than 1000 patients: a single-center experience over 10 years. J Card Surg 2009;24:41-8. doi:10.1111/j.1540-8191.2008.00732.x pmid:19120674.
75. George I, Yerebakan H, Kalesan B, et al. Age alone should not preclude surgery: contemporary outcomes after aortic valve replacement in nonagenarians. J Thorac Cardiovasc Surg 2014;148:1360-1369.e1. doi:10.1016/j.jtcvs.2014.01.015 pmid:24560419.
76. Glaser N, Franco-Cereceda A, Sartipy U. Late haemodynamic performance and survival after aortic valve replacement with the Mosaic bioprosthesis. Interact Cardiovasc Thorac Surg 2014;19:756-62. doi:10.1093/icvts/ivu238 pmid:25016530.
77. Gunter RL, Kilgo P, Guyton RA, et al. Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. Ann Thorac Surg 2013;96:1322-8. doi: 10.1016/j.athoracsur.2013.05.061 pmid:23968758.
78. Higgins J, Jamieson WR, Benhameid O, et al. Influence of patient gender on mortality after aortic valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 2011;142:595-601, 601.e1-2. doi:10.1016/j.jtcvs.2010.05.056. pmid:21247593.
79. Horst M, Easo J, Hlzl PP, et al. The Freedom SOLO valve: mid-term clinical results with a stentless pericardial valve for aortic valve replacement. J Heart Valve Dis 2011;20:704-10.pmid:22655502.
80. Luciani GB, Viscardi F, Cresce GD, Faggian G, Mazzucco A. Seven-year performance of the Edwards Prima Plus stentless valve with the intact non-coronary sinus technique. J Card Surg 2008;23:221-6. doi:10.1111/j.1540-8191.2008.00592.x pmid:18435636.
81. Milano AD, Dodonov M, Celiento M, et al. The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years. Int J Artif Organs 2012;35:481-8. doi:10.5301/ijao.5000103 pmid:22661113.
82. Nguyen TC, Babaliaros VC, Razavi SA, et al. Transcatheter aortic valve replacement has improved short-term but similar midterm outcomes in isolated aortic valve replacement after prior coronary artery bypass grafting. Ann Thorac Surg 2014;98:1316-24. doi:10. 1016/j.athoracsur.2014.05.081 pmid:25149053.
83. Rodes-Cabau J, Pibarot P, Suri RM, et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial. Circ Cardiovasc Interv 2014;7:701-11. doi:10.1161/CIRCINTERVENTIONS.114.001681 pmid:25270901.
84. Scherner M, Madershahian N, Kuhr K, et al. Aortic valve replacement after previous heart surgery in high-risk patients: transapical aortic valve implantation versus conventional aortic valve replacement-a risk-adjusted and propensity score-based analysis. J Thorac Cardiovasc Surg 2014;148:90-7. doi:10.1016/j.jtcvs.2013.07.046 pmid:24125091.
85. Senage T, Le Tourneau T, Foucher Y, et al. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation 2014;130:2012-20. doi:10.1161/CIRCULATIONAHA.114.010400 pmid: 25355912.
86. Stassano P, Di Tommaso L, Vitale DF, et al. Aortic valve replacement and coronary artery surgery: determinants affecting early and long-term results. Thorac Cardiovasc Surg 2006;54:521-7. doi:10.1055/s-2006-924467 pmid:17151966.
87. Une D, Mesana L, Chan V, et al. Clinical Impact of Changes in Left Ventricular Function After Aortic Valve Replacement: Analysis From 3112 Patients. Circulation 2015;132:741-7. doi:10.1161/CIRCULATIONAHA.115.015371 pmid:26304665.
88. Wang TKM, Sathananthan J, Chieng N, Gamble GD, Haydock DA, Ruygrok PN. Aortic valve replacement in over 70- and over 80-year olds: 5-year cohort study. Asian Cardiovasc Thorac Ann 2014;22:526-33. doi:10.1177/0218492313497950 pmid:24867025.
89. Zannis K, Joffre J, Czitrom D, et al. Aortic valve replacement with the perceval S bioprosthesis: single-center experience in 143 patients. J Heart Valve Dis 2014;23:795-802.pmid:25790630.
90. Amabile N, et al. Long-term results of freestyle stentless bioprosthesis in the aortic position: A single center cohort of 500 patients. Eur Heart J 2014;35:686. doi:10.1093/eurheartj/ ehu324. pmid:24474738.
91. Bernet FH, Baykut D, Grize L, Zerkowski HR. Single-center outcome analysis of 1,161 patients with St. Jude medical and ATS open pivot mechanical heart valves. J Heart Valve Dis 2007;16:151-8.pmid:17484464.
92. DOnofrio A, Salizzoni S, Agrifoglio M, et al. Medium term outcomes of transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation. Ann Thorac Surg 2013;96:830-5, discussion 836. doi:10.1016/j.athoracsur. 2013.04.094 pmid:23870695.
93. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7. doi:10.1016/j.jtcvs. 2007.09.011 pmid:18179938.
94. Englberger L, Carrel TP, Doss M, et al. Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study. J Thorac Cardiovasc Surg 2014;148:1681-7. doi:10.1016/j.jtcvs.2014.03.054 pmid:24787699.
95. Grossi EA, Schwartz CF, Yu PJ, et al. High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg 2008;85:102-6, discussion 107. doi:10.1016/j. athoracsur.2007.05.010 pmid:18154791.
96. Hartzell M, Malhotra R, Yared K, Rosenfield HR, Walker JD, Wood MJ. Effect of gender on treatment and outcomes in severe aortic stenosis. Am J Cardiol 2011;107:1681-6. doi: 10.1016/j.amjcard.2011.01.059 pmid:21440885.
97. Hosono M, Sasaki Y, Hirai H, et al. Risk factors for late valve-related mortality after aortic valve replacement in elderly patients. Ann Thorac Cardiovasc Surg 2013;19:368-74. doi: 10.5761/atcs.oa.12.01983 pmid:23237930.
98. Kobayashi KJ, Williams JA, Nwakanma LU, et al. EuroSCORE predicts short- and mid-term mortality in combined aortic valve replacement and coronary artery bypass patients. J Card Surg 2009;24:637-43. doi:10.1111/j.1540-8191.2009.00906.x pmid:20078709.
99. Koos R, Reinartz S, Mahnken AH, et al. Impact of aortic valve calcification severity and impaired left ventricular function on 3-year results of patients undergoing transcatheter aortic valve replacement. Eur Radiol 2013;23:3253-61. doi:10.1007/s00330-013-2961-4 pmid:23821024.
100. Orlowska Baranowska E, Abramczuk E, Grabowski M, et al. Factors affecting long-term survival after aortic valve replacement. Kardiol Pol 2012;70:1120-9.pmid:23180519.
101. Santarpino G, Pfeiffer S, Jessl J, et al. Clinical Outcome and Cost Analysis of Sutureless Versus Transcatheter Aortic Valve Implantation With Propensity Score Matching Analysis. Am J Cardiol 2015;116:1737-43. doi:10.1016/j.amjcard.2015.08.043 pmid:26433277.
102. Sezai A, Osaka S, Yaoita H, et al. Early and Long-Term Outcomes in Japanese Patients Aged 80 Years or Older Undergoing Conventional Aortic Valve Replacement. Ann Thorac Cardiovasc Surg 2015;21:247-53. doi:10.5761/atcs.oa.15-00067 pmid:26004118.
103. Subramanian S, Rastan AJ, Holzhey D, et al. Conventional aortic valve replacement in transcatheter aortic valve implantation candidates: a 5-year experience. Ann Thorac Surg 2012;94:726-9, discussion 729-30. doi:10.1016/j.athoracsur.2012.04.068 pmid:22818966.
104. Svennevig JL, Abdelnoor M, Nitter-Hauge S. Twenty-five-year experience with the Medtronic-Hall valve prosthesis in the aortic position: a follow-up cohort study of 816 consecutive patients. Circulation 2007;116:1795-800. doi:10.1161/CIRCULATIONAHA. 106.677773 pmid:17893279.
105. Timek TA, Turfe Z, Hooker RL, et al. Aortic valve replacement in octogenarians with prior cardiac surgery. Ann Thorac Surg 2015;99:518-23. doi:10.1016/j.athoracsur.2014.08.024 pmid:25195546.
106. Umezu K, Saito S, Yamazaki K, Kawai A, Kurosawa H. Cardiac valvular surgery in dialysis patients: comparison of surgical outcome for mechanical versus bioprosthetic valves. Gen Thorac Cardiovasc Surg 2009;57:197-202. doi:10.1007/s11748-008-0365-1 pmid: 19367452.
107. Vohra HA, Whistance RN, Bolgeri M, et al. Mid-term evaluation of Sorin Soprano bioprostheses in patients with a small aortic annulus
108. Yakubov SJ, Adams DH, Watson DR, et al. CoreValve United States Clinical Investigators. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol 2015;66:1327-34. doi:10.1016/j.jacc.2015.07.042 pmid:26383718.
109. Yamashita MH, Ye J, Jamieson WR, Cheung A, Lichtenstein SV. Conventional aortic valve replacement remains a safe option in patients aged > or = 70 years: a 20-year experience. J Heart Valve Dis 2012;21:148-55.pmid:22645847.
110. Yoshikawa K, Fukunaga S, Arinaga K, et al. Long-term results of aortic valve replacement with a small St. Jude medical valve in Japanese patients. Ann Thorac Surg 2008;85:1303-8. doi:10.1016/j.athoracsur.2007.12.031 pmid:18355515.
111. Leon MB, Smith CR, Mack MJ, et al. PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016;374:1609-20. doi:10.1056/NEJMoa1514616 pmid:27040324.
112. Holzhey D, Mohr FW, Walther T, et al. Current Results of Surgical Aortic Valve Replacement: Insights From the German Aortic Valve Registry. Ann Thorac Surg 2016;101:658-66. doi:10.1016/j.athoracsur.2015.07.090 pmid:26576751.